Altshuler Shaham Ltd - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Altshuler Shaham Ltd ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$26,174
-56.4%
460
-69.9%
0.00%0.0%
Q3 2022$60,000
-7.7%
1,528
+3.1%
0.00%0.0%
Q2 2022$65,000
+66.7%
1,482
+57.2%
0.00%
Q1 2021$39,000
+2.6%
943
+4.9%
0.00%
-100.0%
Q4 2020$38,000
+58.3%
899
-3.0%
0.00%0.0%
Q3 2020$24,000
-57.9%
927
-56.1%
0.00%
-50.0%
Q2 2020$57,0002,1120.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders